Reacción a "Reactions: EMA gives green light to new dengue vaccine "

The approval of the use of this tetravalent vaccine is another clear example that science is key to the protection of human health, especially in the case of tropical and/or emerging diseases such as this one. In recent years we have seen an increase in dengue outbreaks mainly due to a high prevalence of mosquito vectors - transmitters of the virus that causes the disease - in endemic and even non-endemic areas due to the colonisation of new areas and borders by these vectors.  

Dengue is a disease that usually has a much more severe clinical manifestation if we are talking about a second infection. Therefore, having a preventive measure against the severity of the disease is a major achievement for global health.